Jane Street’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.2K | Sell |
11,968
-7,994
| -40% | -$18.1K | ﹤0.01% | 5176 |
|
|
2025
Q1 | $12.7K | Sell |
19,962
-1,691
| -8% | -$1.08K | ﹤0.01% | 5411 |
|
|
2024
Q4 | $22.3K | Sell |
21,653
-5,578
| -20% | -$5.75K | ﹤0.01% | 5608 |
|
|
2024
Q3 | $32.1K | Sell |
27,231
-52,470
| -66% | -$61.9K | ﹤0.01% | 5656 |
|
|
2024
Q2 | $97.2K | Sell |
79,701
-104,047
| -57% | -$127K | ﹤0.01% | 5621 |
|
|
2024
Q1 | $401K | Buy |
183,748
+154,509
| +528% | +$337K | ﹤0.01% | 4328 |
|
|
2023
Q4 | $45.3K | Buy |
+29,239
| New | +$45.3K | ﹤0.01% | 5411 |
|
|
2023
Q3 | – | Sell |
-19,364
| Closed | -$33.3K | – | 5218 |
|
|
2023
Q2 | $33.3K | Sell |
19,364
-21,217
| -52% | -$36.5K | ﹤0.01% | 5005 |
|
|
2023
Q1 | $61.3K | Sell |
40,581
-978
| -2% | -$1.48K | ﹤0.01% | 5077 |
|
|
2022
Q4 | $66.5K | Buy |
+41,559
| New | +$66.5K | ﹤0.01% | 4804 |
|
|
2022
Q2 | – | Sell |
-20,061
| Closed | -$54K | – | 5631 |
|
|
2022
Q1 | $54K | Buy |
20,061
+1,241
| +7% | +$3.34K | ﹤0.01% | 5127 |
|
|
2021
Q4 | $81K | Buy |
+18,820
| New | +$81K | ﹤0.01% | 4728 |
|
|
2021
Q3 | – | Sell |
-84,724
| Closed | -$536K | – | 5273 |
|
|
2021
Q2 | $536K | Buy |
84,724
+67,330
| +387% | +$426K | ﹤0.01% | 3339 |
|
|
2021
Q1 | $134K | Buy |
17,394
+2,045
| +13% | +$15.8K | ﹤0.01% | 4457 |
|
|
2020
Q4 | $101K | Sell |
15,349
-3,811
| -20% | -$25.1K | ﹤0.01% | 3637 |
|
|
2020
Q3 | $127K | Buy |
19,160
+3,121
| +19% | +$20.7K | ﹤0.01% | 3386 |
|
|
2020
Q2 | $134K | Buy |
+16,039
| New | +$134K | ﹤0.01% | 3572 |
|